MJA Podcasts 2022 Episode 43: New hope for resistant hypertension, with Prof Markus Schlaich

Vol 217, Issue 11: 28 November 2022. Professor Markus Schlaich is Director of the Dobney Hypertension Centre in Perth, and Dobney Chair of Clinical Research at the University of Western Australia. His recently published research on dual endothelin antagonist aprocitentin for resistant hypertension can be found at The Lancet. His op-ed for InSight+ is free to access and can be found here. With MJA news and online editor Cate Swannell. 23 mins, 41 secs.